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Background: To investigate the efﬁcacy of continuous and pulsed ultrasound (US) in the management of
knee osteoarthritis (OA).
Design: This systematic review and network meta-analysis covered 12 trials in total. Electronic databases
including MEDLINE, Embase and Cochrane Library were searched through to identify randomized
controlled trials comparing the two modes of US with control interventions (sham or blank) or with each
other. Bayesian network meta-analysis was used to integrate both the direct and indirect evidences on
treatment effectiveness.
Results: Pulsed US (PUS) is more effective in both pain relief and function improvement when compared
with the control group; but for continuous US (CUS), there is only a signiﬁcant difference in pain relief in
comparison with the control group. In addition, no matter in terms of pain intensity or function at the
last follow-up time point, PUS always exhibited a greater probability of being the preferred mode.
However, the evidence of heterogeneity and the limitation in sample size of some studies could be a
potential threat to the validity of results.
Conclusions: Our ﬁndings indicated that PUS, with a greater probability of being the preferred mode, is
more effective in both pain relief and function improvement when compared with the control group.
However, CUS could only be considered as a pain relief treatment in the management of knee OA. The
ﬁndings also conﬁrmed that none of these modes is dangerous.
Level of evidence: Level II, systematic review and network meta-analysis of randomized controlled trials.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a progressive rheumatic disease, the
incidence of which keeps rising with the growth of the ageing
population in many societies. About 9 million people suffer from
symptomatic, radiographically conﬁrmed knee OA in the USA1. The
main complaints of knee OA include: pain during body moving or
weight bearing, stiffness, swelling, deformity and decreased
walking time and distance. Therefore, the relevant therapies
generally aim to relieve pain, improve functionality and mitigateG.-h. Lei, Department of Or-
y, #87 Xiangya Road, Chang-
(C. Zeng), lgh9640@sina.cn,
ternational. Published by Elsevier Ldisability for enhancing the quality of life. As the prevalence of knee
OA increases2, the increasing rates of knee arthroplasty, which is
the only effective way of late phase, has made the identiﬁcation of
effective conservative treatments a high priority.
Therapeutic ultrasound (US), based on the application of sound
waves in tissues, is one of the most widely used physical agents in
knee OA. There are two modes of US, continuous and pulsed.
Continuous US (CUS) generates thermal effects by stimulating the
process of tissue regeneration, changing cell membrane perme-
ability and increasing intracellular calcium, while pulsed US (PUS)
mainly produces non-thermal effects to increase tissue meta-
bolism, enhance ﬁbrous tissue extensibility and elevate pain
threshold3e5. In the past few years, a rapidly growing interest in
testing the effects of US has been observed, but no agreement was
reached yet; especially, there is no exact conclusion on which
modality of US (continuous or pulsed) is more effective in pain
relief and functionality improvement of knee OA.td. All rights reserved.
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(OARSI) developed the guidelines (2014) for non-surgical man-
agement of knee OA6, which is the most up-to-date guideline till
present. The recommendation level of US for knee-only OA was
uncertain based on the results of two systematic reviews7,8 pub-
lished in 2010 and one randomized controlled trial (RCT)9 pub-
lished in 2012. Although these two previous systematic reviews
covered several RCTs (one of them reported a statistically signiﬁ-
cant pain relief for knee OA7), evidencewas limited because only six
RCTs were available at that time. It is worth mentioning that
whether the physical function was actually improved remains un-
clear. Furthermore, the authors admitted that the small sample size
and low quality of trials included in their mode subgroup analyses
(continuous or pulsed) inhibited further inferences7.
Network meta-analysis has been recently developed to evaluate
the relative effectiveness of several interventions and synthesize
evidence across a network of randomized trials. The mainly
strength of network meta-analysis is to combine the direct (studies
compared PUS with CUS directly) and indirect estimates (studies
compared PUS with CUS via control group) and calculated a mixed
effect size as the weighted average of the direct evidence and the
indirect evidence10. Comparing with traditional meta-analysis,
network meta-analysis is able to offer information on compari-
sons for which no trails exist. In our case, the application of indirect
evidence can improve the precision of the direct estimate by
shortening the width of the conﬁdence intervals in contrast to
direct estimates alone11.
Considering the accumulation of new trials, this paper intended
to conduct an up-to-date systematic review and Bayesian network
meta-analysis covering all the available direct and indirect evi-
dences on US effects in order to generate a uniﬁed and coherent
analysis for all RCTs12e15. The objective of this study was to assess
the effects of US (continuous or pulsed) on pain relief and function
improvement for knee OA.Materials and methods
Literature search
The electronic databases of Medline, Embase and Cochrane li-
brary were searched through using a series of logic combination of
keywords and text words related to OA, interested interventions
and randomized controlled trials (Appendix 1). The latest electronic
search was conducted in February 2014 to identify the references of
the retrieved papers and reviews. In addition, the following web-
sites were searched through manually to identify unpublished and
ongoing studies: Current Controlled Trials (http://www.controlled-
trials.com/), ClinicalTrials.gov (http://www.clinicaltrials.gov/)and
the World Health Organization International Clinical Trials Registry
(http://apps.who.int/trialsearch/Default.aspx).Study selection
Two researchers reviewed all the retrieved abstracts and full
texts independently. Disagreements were resolved through dis-
cussions and consultations to another researcher. Those papers
meeting the following criteria were included in the analysis: (1)
randomized controlled trials; (2) patients with knee OA (3)
studies containing at least two of the following eligible treat-
ments: PUS, CUS and control group (blank or sham); (4) studies
reporting the pain or function outcomes of patients; (5) English
literature. On the other hand, the trials with unbalanced addi-
tional modality (e.g., education or exercise) between groups were
excluded.Quality assessment
Two researchers evaluated the methodological quality sepa-
rately. The modiﬁed oxford score16,17, a scale ranged from 0 to 7
according to the descriptions of randomization, concealment allo-
cation, blinding method and reporting of participant withdrawals,
was used to measure the methodological quality of included
studies.Outcome measures
The primary goal of this study was to identify the effectiveness
of pain management and function improvement by applying the
PUS or CUS therapy respectively. The degree of pain intensity after
treatment was used as the measure of pain management effect. If a
study reported multiple pain scales, the highest one on the hier-
archy of pain scale related outcomes was selected, as described by
Jüni and colleagues18. The WOMAC function was the preferred
measure for function. If a study did not measure or report the
WOMAC function, WOMAC total, Lequesne Index or other func-
tional measurement scales were used in the analysis instead. If a
study reported outcomes at multiple time points after treatment,
only the data from the ﬁnal follow-up time point was extracted for
analysis. The effect of painmanagement and function improvement
was expressed as the standard mean differences (SMD) between
different treatment arms. A negative value of SMD indicates lower
pain intensity and better status of function after treatment.Statistical analysis
The random effect Bayesian network meta-analysis was per-
formed to compare the pain management and function improve-
ment effect between different modes of US therapy for knee OA.
The advantage of network meta-analysis is that it allows indirect
comparisons of interventions among primary trials. In this study,
the random effect Bayesian network meta-analysis was performed
using WinBUGS software (version 1.4.3, MRC Biostatistics Unit,
Cambridge, UK), R version 3.0.2 (The R Foundation for Statistical
Computing) and STATA software (version 11.0, StataCorp, College
Station, TX). The codes of random effect models for multi-arm trials
were available at http://www.mtm.uoi.gr/ (Appendix 2). Three
Markov chains ran simultaneously with different initial values
chosen arbitrarily. A total of 50,000 simulations were generated for
each of the three sets of initial values, and the ﬁrst 10,000 simu-
lations were discarded due to the burn-in period. The pooled effect
sizes were reported from the median of the posterior distribution.
The corresponding 95% credible intervals with the 2.5th and 97.5th
percentiles of the posterior distribution were used in this study,
which could be interpreted in away similar to the conventional 95%
conﬁdence intervals. In order to estimate the network inconsis-
tency between indirect and direct estimates in each closed loop, the
absolute difference between the direct and indirect treatment ef-
fect estimates was calculated. Loops with the lower CI limit did not
reach the zero line were considered to represent statistically sig-
niﬁcant inconsistency19. The ﬁt of the model to data can be
measured by calculating the posterior mean residual deviance. If
the mean of the residual deviance is similar to the number of data
points of the model, it indicates that the model ﬁts the data
adequately20. All treatments were then ranked based on the level of
effectiveness according to their posterior probabilities (ﬁrst best,
second best, third best, etc.). The probability values were summa-
rized and reported as the surface under the cumulative ranking
(SUCRA)21. SUCRA is equal to 1 for the best treatment, and 0 for the
worst treatment.
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STATA software (version 11.0, StataCorp, College Station, TX). The
heterogeneity was tested by Q statistics (P  0.05 was considered
heterogeneous) and I2 statistics, which measures the percentage of
the total variation across various studies (I2  50% was considered
heterogeneous). To evaluate the publication bias, Begg's tests22
were performed, where a P value less than 0.5 was considered to
reﬂect publication bias.Results
Study selection and characteristics
Figure 1 showed the selection process of the included trials in
this study. A total of 1769 records were identiﬁed from the pre-
liminary database and website search and 993 records were
selected after removing duplicates. Then 927 records excludedwith
reasons and 66 full-text trials were evaluated for eligibility. Even-
tually, 12 studies were included in this research9,23e33. The char-
acteristics of the included studies were listed in Table I. The
methodological quality assessment (Table II) showed that three
studies belonged to low quality (score  3), four belonged to me-
dium quality (scored 4 or 5), and the rest belonged to high quality
(scored 6 or 7). Data from eight studies involving a total of 525
patients with knee OA was available for network meta-ana-
lysis9,23e29. Figure 2 showed the network structure of the com-
parisons for the primary outcomes.Fig. 1. Flowchart for the selePain intensity
The results of network meta-analysis and pairwise meta-
analysis were reported in Table III. PUS achieved a signiﬁcantly
lower pain intensity compared to the control group (SMD: 0.59,
95%CI: 0.89 to 0.26), and CUS achieved a signiﬁcantly better
effect of pain management compared to the control group
(SMD: 0.41, 95%CI: 0.67 to 0.07). However, there was no sig-
niﬁcant difference between the PUS and CUS group in terms of pain
intensity after treatment (SMD: 0.18, 95%CI: 0.94 to 0.37). No
evidence of inconsistency between direct and indirect estimates
was found in this network meta-analysis. Evaluation of the good-
ness of ﬁt indicated adequate ﬁt with a posterior mean residual
deviance of 20.07 (19 data points). The distribution of probability of
each treatment for this outcome was shown in Fig. 3. PUS is most
likely to be the best treatment (93%) compared to CUS (56%) and the
control group (0%). Pairwise meta-analysis showed nearly the same
results (Table III). Signiﬁcant evidence of heterogeneity was only
observed in the comparison between PUS and the control group
(P ¼ 0.07, I2 ¼ 54%). There was no publication bias among various
studies. The original pain outcomes of the studies which were not
included in meta-analysis were reported in Appendix 3.
Function
Table III also showed the outcomes of networkmeta-analysis for
function. It indicated that only the PUS therapy was signiﬁcantly
more effective in terms of function improvement compared to thection of included trials.
Table I
Characteristics of the included studies
Study Groups Balance* N Age
(years)
Gender
(M/F)
Mean
BMI
Parameters of intervention Interested outcome
(pain/function)
Test timez
Loyola-Sanchez
2012
G1: PUS
G2: sham
None 14
13
62.6
61.2
3/11
3/10
34
30.4
9.5 min  3 times  8 weeks,
20% duty cycle, 1 MHz,
average temporal intensity:
0.2 W/cm2, therapeutic
dose: 112.5 J/cm2
VAS/WOMAC function 8 weeks
Ulus 2012 G1: CUS
G2: sham
Hot pack,
interferential
current,
exercise
20
20
60.7
60.3
3/17
3/17
31.6
31.1
10 min  5 times  3 weeks,
1 MHz, 1 W/cm2
VAS/WOMAC function
and LI
0 week
Tascioglu 2010 G1: CUS
G2: PUS
G3: sham
None 27
28
27
59.7
61.4
60
10/17
7/21
9/18
30
30.8
28.7
5 min  5 times  2 weeks,
1 MHz, 2 W/cm2
VAS/WOMAC total 2 days
€Ozg€onenel 2009 G1: CUS
G2: sham
None 34x
33
53.6
56.2
6/28
7/26
None 5 min  5 times  2 weeks,
1 MHz, 1 W/cm2
VAS/WOMAC function 2 days
Huang 2005a G1: PUS
G2: blank
Exercise 32
31
65y 27/113y None 5 min  3 times  8 weeks,
1 MHz, 2.5 W/cm2
VAS/LI 0, 1 year
Huang 2005b G1: CUS
G2: PUS
G3: blank
Exercise,
hot pack
48
56
42
62y 23/97y None 5 min  3 times  8 weeks,
1 MHz, continuous:
1.5 W/cm2; pulsed: 2.5 W/cm2
VAS/LI 0, 1 year
Cetin 2008 G1: CUS
G2: blank
Exercise,
hot pack
20x
20
57.6
61.1
Only
Females
29.8
27.7
10 min  3 times  8 weeks,
1 MHz, 1.5 W/cm2
VAS/LI 0 week
Cakir 2013 G1: CUS
G2: PUS
G3: sham
Exercise 20
20
20
56.9
58.2
57.1
6/14
4/16
3/17
27.9
30.9
29.5
12 min  5 times  2 weeks,
CUS: 1 MHz, 1 W/cm2;
PUS: 1 MHz, 1 W/cm2
VAS/WOMAC function 0, 6 months
Yang PF 2011 G1: PUS
G2: sham
None 50
50
58.3y 72/15y None 30 min  5 treatments VAS/LI 0,4 weeks
Falconer J 1992 G1: CUS
G2: sham
None 34x
35x
69.4x
65.7x
8/26
11/35
BMI 30 min  12 treatments
(2e3 times per week over
4e6 weeks); increments of
0.1 W/cm2 to maximum 2.5 W/cm2
VAS/gait velocity 0, 12 weeks
Külcü 2009 G1: CUS
G2: blank
None 15
15
63.1
62
2/13
3/12
e 10 min  5 sessions  3 weeks;
1 MHz, 1.5 W/cm2
VAS
WOMAC
0 week
Kapidzic 2011 G1: CUS
G2: sham
Thermotherapy
and exercises
40
50
60y e e 5 min, 3 weeks, 0.8 W/cm2 Likert's scale/WOMAC
function and LI
0 week
W, watt; ms, microsecond; N, number of subjects; M, male; F, female; BMI, Body Mass Index; VAS, visual analogue scale (0e10); WOMAC function, function subscale of
Western Ontario andMcMaster University Osteoarthritis Index (0e68);WOMAC total, Western Ontario andMcMaster University Osteoarthritis Index consists three subscales
(pain, stiffness and functional status, 0e96); LI, Lequesne index (0e26).
* Usual cares which were balance between groups.
y Only data for the whole trial is available.
z 0 means at the end of the treatment.
x Only data from the baseline is available.
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signiﬁcant difference between CUS and the control group
(SMD: 0.26, 95%CI: 0.79 to 0.28), and between PUS and CUS
(SMD: 0.31, 95%CI: 0.94 to 0.37) in terms of function improve-
ment. There was no evidence of inconsistency between the direct
and indirect evidences. The model had an adequate ﬁt to data, with
a posterior mean residual deviance of 19.64 (19 data points).
Figure 4 displayed the distribution of probability of each treatment
ranked at each of the three possible positions. According to the
result of the posterior probability values of rank, it was found that
PUS is most likely (98%) to be the best treatment for function
improvement, followed by CUS (51%) and the control group (9%).
The pairwise meta-analysis also ended up with similar results as
the network meta-analysis in terms of function. However, there
was signiﬁcant heterogeneity between the two direct comparisons
(PUS vs control: P¼ 0.00, I2¼ 83%; PUS vs CUS: P¼ 0.005, I2¼ 81%).
Based on the P values of Beggs' test, publication bias did not exist
among various studies. The functional results of the studies
excluded from this network meta-analysis were reported in
Appendix 3.
Adverse effects
There were only three trials that reported adverse effects. Two
of them claimed that no adverse effect related to the CUStreatment was observed, and one study reported the adverse ef-
fect of electric shock/stinging sensation related to the PUS treat-
ment. However, there was no signiﬁcant difference between the
intervention and the control group in terms of the incidence of
adverse effect.
Discussion
This network meta-analysis reviewed two kinds of therapeutic
US (continuous or pulsed) in terms of pain relief and function
improvement for patients with knee OA. It was found that PUS is
more effective in terms of both pain relief and function improve-
ment when comparedwith the control group (blank and sham), but
for CUS, the signiﬁcant difference only exists in pain relief in
comparison with the control group. In addition, no matter in terms
of pain intensity or function at the last follow-up time point, PUS is
most likely to be the preferred mode.
Recently, a provincial survey conducted in Canada indicated
that a majority of physical therapists (85%) expressed interest in
the effectiveness of US in pain relief and physical function34.
However, the recommendations mentioned in the current clinical
practice guidelines have not arrived at any agreement which
against helping policy makers, service commissioners, and pro-
viders to judge the efﬁcacy of US therapy. One guideline rec-
ommended US for OA management35; three guidelines were
Table II
Methodological evaluation of included studies
Study Randomized
method
Concealment
allocation
Blinding
method
Follow-up Total
score
Loyola-Sanchez 2012 2 2 2 1 7
Ulus 2012 2 2 2 1 7
Tascioglu 2010 1 2 2 1 6
€Ozg€onenel 2009 1 0 2 1 4
Huang 2005a 1 2 2 1 6
Huang 2005b 1 2 2 1 6
Cetin 2008 1 0 2 1 4
Cakir 2013 2 0 2 1 5
Yang 2011 1 0 0 1 2
Falconer 1992 1 0 2 1 4
Külcü 2009 2 0 0 1 3
Kapidzic 2011 1 0 0 1 2
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one, regarded US as an uncertain appropriate modality6,39,40;
other four guidelines did not even mention about US as a treat-
ment option41e44. Two reviews published in 2010 involving ﬁve
and six randomized controlled trials respectively reached a
similar conclusion that therapeutic US might be beneﬁcial (painCUS
PUS
control
5(224) 5(328)
6(286)
6(331)
3(147)
3(199)
Fig. 2. Structure of network formed by interventions and their direct comparisons. The
lines between treatment nodes indicate the direct comparisons made within ran-
domized trials. The width of the lines is proportional to the number of trials comparing
each pair of treatments. Numbers represent numbers of trials (number of analyzed
patients) per comparison. Inside numbers are for pain outcome and outside numbers
are for function outcome.
Table III
Results of network meta-analysis and pairwise meta-analysis
Comparison Network meta-analysis,
SMD (95%CI)
Pairwise meta-an
SMD (95%CI)
PUS vs control
Pain 0.59 (0.89, 0.26) 0.55 (0.90, 0
Function 0.57 (1.12, 0.01) 0.63 (1.31, 0.0
CUS vs control
Pain 0.41 (0.67, 0.07) 0.40 (0.67, 0
Function 0.26 (0.79, 0.28) 0.24 (0.47, 0
PUS vs CUS
Pain 0.18 (0.49, 0.17) 0.13 (0.41, 0.1
Function 0.31 (0.94, 0.37) 0.33 (1.10, 0.4relief and function improvement) for patients with knee OA7,8.
With the accumulation of evidences, especially for the mode
(continuous or pulsed) subgroup, this network meta-analysis
further supported that PUS could be the preferred mode in
terms of both pain relief and function improvement without
signiﬁcant adverse effects.
In vitro studies have supported the effects of PUS in inducing
chondrocyte proliferation and matrix production in human artic-
ular cartilage45e49. Meanwhile, based on a number of researches
establishing animal models of cartilage injury, in vivo experiments
also showed that low intensity PUS was beneﬁcial to cartilage
health50e55. Therewas also a study suggesting that PUSwith topical
lidocaine gel could induce greater anaesthetic effects compared to
CUS with topical lidocaine gel and lidocaine application alone56.
The ﬁndings of these studies were consistent with the results ob-
tained here. On the other hand, unlike the athermal mechanical
effects generated by the application of PUS, CUS aims to generate
thermal effects which could increase capillary permeability and
tissue metabolism, enhance ﬁbrous tissue extensibility, and espe-
cially elevate the pain threshold5,57. Likewise, CUS was proved to be
an effective way only in pain relief for patients with knee OA in this
study.
As far as we know, this is the ﬁrst network meta-analysis of
US for knee OA, which compiled evidences from both direct and
indirect comparisons for evaluating the relative effectiveness in
pain relief and function improvement. In addition, this study
overcame two limitations which were admitted in the previous
classical meta-analysis7. One is the effects of co-interventions
(including education or exercise) which could be effective in
pain relief and function improvement. The control group of this
study was limited to sham or blank control, and the additional
modality was required to be balanced between groups in order to
eliminate the potential impact of standard care. Under such
circumstance, it is meaningful to conclude that US was effective
as long as the results were signiﬁcant. Otherwise, it is uncom-
fortable to draw a deﬁnite conclusion whether US is beneﬁcial or
not when the results were non-signiﬁcant. The other limitation
resolved is the powerful mode subgroup analysis which was
conducted in this network meta-analysis. Furthermore, Beggs'
test suggested that publication bias was not observed among the
included studies.
Nevertheless, the limitations of this study should not be ignored.
Firstly, variations of US sessions, doses and differences in ﬁnal
follow-up time point might contribute to the signiﬁcant evidence of
heterogeneity, particularly for the possible doseeresponse patterns
which could greatly affect the performance of US. However,
because of the limited number of included trials and insufﬁcient
descriptions of treatment parameters, this study could not explore
it in depth. Fortunately, no obvious evidence of inconsistency was
observed in this network meta-analysis. Secondly, several includedalysis, Heterogeneity (P/I2) Publication bias
(P value of Beggs' test)
.21) 0.07/54% 0.086
6) 0.00/83% 0.462
.14) 0.21/30% 1.000
.00) 0.29/18% 1.000
5) 0.71/0% 1.000
5) 0.005/81% 0.296
0
.
2
.
4
.
6
.
8
1
0
.
2
.
4
.
6
.
8
1
0
.
2
.
4
.
6
.
8
1
1 2 3 1 2 3
1 2 3
CUS PUS
control
Cu
m
u
la
tiv
e 
Pr
o
ba
bi
lit
ie
s
RankGraphs by Treatment
Fig. 3. Rankings for pain intensity. Graph displays distribution of probabilities for each treatment. X-axis represents the possible rank of each treatment (from the best rank to worse
according to the outcomes), Y-axis represents the cumulative probability for each treatment to be the best option, among the best two options, among the best three options, and so on.
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all treatment courses. It is uncertain whether these effects may
diminish after a long time. Thirdly, the low level of methodological
quality and the limitation in sample size of some studies could be a
potential threat to the validity of results. Fourthly, this study only
focused on the effectiveness of pain relief and function improve-
ment, it is difﬁcult to measure other indices in this Bayesian
network meta-analysis.
Conclusion
Our ﬁndings indicated that PUS, with a greater probability of
being the preferred mode, is more effective in both pain relief and0
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Fig. 4. Rankings for function. Graph displays distribution of probabilities for each treatmen
according to the outcome), Y-axis represents the cumulative probability for each treatment tofunction improvement when compared with the control group.
However, CUS could only be considered as a pain relief treatment in
themanagement of knee OA. The ﬁndings also conﬁrmed that none
of these modes is dangerous.
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20120162110036).Appendix 1. Search strategies for Pubmed, Ovid/MEDLINE,
The Cochrane Library and Ovid/EMBASE database
Pubmed
1. osteoarthro*[tiab] or gonarthriti*[tiab] or gonarthro*[tiab] or
coxarthriti*[tiab] or coxarthro*[tiab] or osteo?arthritis[tiab]
2. (knee*[tiab] or joint*[tiab]) and (pain*[tiab] or discomfort*
[tiab])
3. (knee*[tiab] or joint*[tiab]) and stiff*[tiab]
4. 1 or 2 or 3
5. randomized[tiab]
6. placebo[tiab]
7. controlled[tiab]
8. random*[tiab]
9. trial*[tiab]
10. groups[tiab]
11. ((singl*[tiab] or doubl*[tiab] or tripl*[tiab]) and (mask*[tiab]
or blind*[tiab]))
12. Or/5-11
13. Ultrasonography[tiab]
14. Ultrasonic[tiab]
15. ultrasound*[tiab] or ultrasonic*[tiab]
16. short[tiab] and wave[tiab]
17. ultrasonograph*[tiab]
18. Ultraso*[tiab]
19. Or 13-18
20. 4 and 12 and 19Ovid/MEDLINE
1. osteoarthriti$.ti,ab,sh.
2. osteoarthro$.ti,ab,sh.
3. osteo?arthritic.ti,ab,sh.
4. gonarthriti$.ti,ab,sh.
5. gonarthro$.ti,ab,sh.
6. coxarthriti$.ti,ab,sh.7. coxarthro$.ti,ab,sh.
8. arthros$.ti,ab.
9. arthrot$.ti,ab.
10. ((knee$ or joint$) adj3 (pain$ or ach$ or discomfort$)).ti,ab.
11. ((knee$ or joint$) adj3 stiff$).ti,ab
12. Or/1-11
13. randomized controlled trial.pt.
14. controlled clinical trial.pt.
15. randomi?ed.ab.
16. placebo.ab,tw.
17. controlled.ti,ab
18. randomly.ti,ab.
19. trial.ti,ab.
20. groups.ti,ab
21. ((randomized controlled trials) or (random$ allocation) or
(double blind) or (single blind)).tw
22. ((singl$ or doubl$ or tripl$) and (mask$ or blind$)).tw
23. Or/13-22
24. exp ultrasonography/
25. exp Ultrasonic Therapy/
26. (ultrasound$ or ultrasonic$).tw.
27. short wave therapy.tw.
28. ultrasonograph$.tw.
29. Ultraso$.ti,ab,sh
30. Or/24-29
31. 12 and 23 and 30The Cochrane Library
#1 (osteoarthritis* OR osteoarthro* OR gonarthriti* OR gonar-
thro* OR coxarthriti* OR coxarthro* OR arthros* OR arthrot*
OR ((knee* OR joint*) near/3 (pain* OR ach* OR discomfort*))
OR ((knee*OR joint*) near/3 stiff*))
#2 MeSH descriptor Osteoarthritis explode all trees
#3 #1 or #2
#4 short wave therapy in Clinical Trials
#5 ultrasonograph in Clinical Trials
#6 (ultrasound* or ultrasonic*) in Clinical Trials
#7MeSH descriptor Ultrasonography explode all trees
#8 MeSH descriptor Short-Wave Therapy explode all trees
#9 #4 or #5 or #6 or #7 or #8
#10 #3 and #9Ovid/EMBASE
1. osteoarthriti$.ti,ab,sh.
2. osteoarthro$.ti,ab,sh.
3. osteo?arthritic.ti,ab,sh.
4. gonarthriti$.ti,ab,sh.
5. gonarthro$.ti,ab,sh.
6. coxarthriti$.ti,ab,sh.
7. coxarthro$.ti,ab,sh.
8. arthros$.ti,ab.
9. arthrot$.ti,ab.
10. ((knee$ or joint$) adj3 (pain$ or ach$ or discomfort$)).ti,ab.
11. ((knee$ or joint$) adj3 stiff$).ti,ab
12. Or/1-11
13. randomized controlled trial.pt.
14. controlled clinical trial.pt.
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16. placebo.ab,tw.
17. controlled.ti,ab
18. randomly.ti,ab.
19. trial.ti,ab.
20. groups.ti,ab
21. ((randomized controlled trials) or (random$ allocation) or
(double blind) or (single blind)).tw
22. ((singl$ or doubl$ or tripl$) and (mask$ or blind$)).tw
23. Or/13-22
24. exp ultrasonography/
25. exp Ultrasonic Therapy/
26. (ultrasound$ or ultrasonic$).tw.
27. short wave therapy.tw.
28. ultrasonograph$.tw.
29. Ultraso$.ti,ab,sh
30. Or/24-29
31. 12 and 23 and 30Appendix 2. WinBUGS codes of random effect models for
multi-arm trials
Appendix 3. Results of the studies not included in the network meta-analysis
Study Groups Pain scale/function scale Outcome of pain Outcome of function
Original data Signiﬁcance of
difference
Original data Signiﬁcance of
difference
Yang PF 2011 G1: PUS
G2: placebo
VAS/LI Effect index
G1: 0.36 ± 0.28
G2: 0.10 ± 0.19
P ¼ 0.000 Effect index
G1: 0.31 ± 0.42
G2: 0.03 ± 0.11
P ¼ 0.000
Falconer J 1992 G1: CUS
G2: placebo
VAS/gait velocity NR NS NR NS
Külcü 2009 G1: CUS
G2: blank
VAS/WOMAC Median (range)
G1: 2 (0e6)
G2: 5 (2e10)
P < 0.0001 Median (range)
G1: 11.5 (0e26)
G2: 24 (18e30)
P < 0.0001
Kapidzic 2011 G1: CUS
G2: placebo
Likert's scale/WOMAC
function and LI
Difference of before
and after treatment
G1: 0.83 ± 0.51
G2: 0.53 ± 0.40
P < 0.05 Difference of before
and after treatment
G1: 0.61 ± 0.55
G2: 0.38 ± 0.70
P < 0.05
NS: not signiﬁcant, NR: not report.
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